IGC Pharma (IGC) Interest Coverage Ratio (2010 - 2017)
IGC Pharma (IGC) reported Interest Coverage Ratio of 7.81 for Q4 2017, up 5.96% year-over-year from 7.38 in Q4 2016, and down 21.33% quarter-over-quarter from 6.44 in Q3 2017.
IGC Pharma (IGC) Interest Coverage Ratio (2010 - 2017) Analysis & Trends
IGC Pharma (IGC) has 8 years of Interest Coverage Ratio data on file, last reported at 7.81 in Q4 2017.
- Interest Coverage Ratio for Q4 2017 came in at 7.81, up 5.96% year-over-year; the trailing twelve-month figure through Sep 2018 was 42.18 (down 418.54% YoY), and the FY2017 annual result was 9.19, down 67.72% from the prior year.
- Interest Coverage Ratio retreated to 7.81 in Q4 2017 per IGC's latest filing, from 6.44 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 9.87 in Q1 2015 and troughed at 26.53 in Q1 2014.
- A 5-year average of 7.5 and a median of 7.45 in 2015 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2013 and 2015: Interest Coverage Ratio slumped 925.84% in 2013, then jumped 137.21% in 2015.
- A 5-year view of Interest Coverage Ratio shows it stood at 5.6 in 2013, then plunged by 43.86% to 8.06 in 2014, then rose by 8.73% to 7.35 in 2015, then decreased by 13.01% to 8.31 in 2016, then advanced by 5.96% to 7.81 in 2017.
- Business Quant data shows IGC's Interest Coverage Ratio at 7.81 in Q4 2017, 6.44 in Q3 2017, and 8.9 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -7.81 |
| Sep 30, 2017 | -6.44 |
| Jun 30, 2017 | -8.90 |
| Mar 31, 2017 | -8.45 |
| Dec 31, 2016 | -8.31 |
| Sep 30, 2016 | -10.69 |
| Jun 30, 2016 | -7.37 |
| Mar 31, 2016 | -0.96 |
| Dec 31, 2015 | -7.35 |
| Sep 30, 2015 | -7.53 |
| Jun 30, 2015 | -4.16 |
| Mar 31, 2015 | 9.87 |
| Dec 31, 2014 | -8.06 |
| Sep 30, 2014 | -9.60 |
| Jun 30, 2014 | -18.80 |
| Mar 31, 2014 | -26.53 |
| Dec 31, 2013 | -5.60 |
| Sep 30, 2013 | -6.29 |
| Jun 30, 2013 | -2.33 |
| Mar 31, 2013 | -4.76 |